CPHI Milan 2024: Flavonoids in Pharmaceuticals

Pharmaceutical Technology®Europe sat down with Álvaro Nocete Díaz, Pharma Division Manager at HTBA, about the benefits of flavonoids and their use in the pharmaceutical industry. Nocete Díaz discusses how the flavonoid industry has developed, its future, and how to ensure quality when using flavonoids in pharmaceuticals.

“When you think about flavonoids, and again being phytochemicals, it is very important to think about the main source, which is normally a fruit, a vegetable, or an herb,” says Nocete Díaz. “So, the first stage in developing a flavonoid as an ingredient, either for the pharma or nutraceutical industry, will be to have a very strong and robust supply chain of those materials, because they come from crops, right? Then it is also very important to control the quality assurance.”

Nocete Díaz points to product standardization, identification, and quantification as important factors for quality assurance for flavonoids in pharmaceuticals. “[D]eveloping a method of analysis for those products is also very important when moving from the first stage of the natural source to a pure natural or active ingredient, which can be used in the pharmaceutical industry. [It is] also very important to consider the regulatory work that needs to be done, both from the agencies and from the industry, to control all [these aspects of quality],” Nocete Díaz says.

Click the above video to watch the full interview.

Visit HTBA at Booth 2B74. CPHI Milan is being held from Oct. 8–10, 2024 in Milan, Italy.